Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Biomolecules
|
February 25, 2022
Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer
Sarah Koushyar, Valerie S Meniel, Toby J Phesse, et al.
BMC Cancer
|
June 7, 2008
A limited role for p53 in modulating the immediate phenotype of Apc loss in the intestine
Karen R Reed, Valerie S Meniel, Victoria Marsh, et al.
British Journal of Cancer
|
March 3, 2026
Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity
Daniel J Turnham, Rhiannon French, Fiona M Frame, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 27, 2008
B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver
Karen R Reed, Dimitris Athineos, Valerie S Meniel, et al.
British Journal of Cancer
|
October 5, 2024
The αvβ6 integrin specific virotherapy, Ad5<sub>NULL</sub>-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinoma
Luned M Badder, James A Davies, Valerie S Meniel, et al.
Biochemical and Biophysical Research Communications
|
September 4, 2013
Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC)
Abeer Hammoudi, Fei Song, Karen R Reed, et al.
Nature
|
March 23, 2007
Myc deletion rescues Apc deficiency in the small intestine
Owen J Sansom, Valerie S Meniel, Vanesa Muncan, et al.
Cancer Research
|
January 10, 2019
<i>Frizzled-7</i> Is Required for Wnt Signaling in Gastric Tumors with and Without <i>Apc</i> Mutations
Dustin J Flanagan, Nick Barker, Natasha S Di Costanzo, et al.
Cells
|
April 26, 2024
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer
Daniel J Turnham, Manisha S Mullen, Nicholas P Bullock, et al.
Molecular Therapy Oncolytics
|
April 11, 2022
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10
Emily A Bates, James A Davies, Jana Váňová, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Biomolecules
|
February 25, 2022
Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer
Sarah Koushyar, Valerie S Meniel, Toby J Phesse, et al.
BMC Cancer
|
June 7, 2008
A limited role for p53 in modulating the immediate phenotype of Apc loss in the intestine
Karen R Reed, Valerie S Meniel, Victoria Marsh, et al.
British Journal of Cancer
|
March 3, 2026
Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity
Daniel J Turnham, Rhiannon French, Fiona M Frame, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 27, 2008
B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver
Karen R Reed, Dimitris Athineos, Valerie S Meniel, et al.
British Journal of Cancer
|
October 5, 2024
The αvβ6 integrin specific virotherapy, Ad5<sub>NULL</sub>-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinoma
Luned M Badder, James A Davies, Valerie S Meniel, et al.
Biochemical and Biophysical Research Communications
|
September 4, 2013
Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC)
Abeer Hammoudi, Fei Song, Karen R Reed, et al.
Nature
|
March 23, 2007
Myc deletion rescues Apc deficiency in the small intestine
Owen J Sansom, Valerie S Meniel, Vanesa Muncan, et al.
Cancer Research
|
January 10, 2019
<i>Frizzled-7</i> Is Required for Wnt Signaling in Gastric Tumors with and Without <i>Apc</i> Mutations
Dustin J Flanagan, Nick Barker, Natasha S Di Costanzo, et al.
Cells
|
April 26, 2024
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer
Daniel J Turnham, Manisha S Mullen, Nicholas P Bullock, et al.
Molecular Therapy Oncolytics
|
April 11, 2022
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10
Emily A Bates, James A Davies, Jana Váňová, et al.
Page
of 2